A New King of The GLP-1s Could Be Crowned – Cardiac Wire
A New King of The GLP-1s Could Be Crowned Cardiac Wire‘Godzilla’ of weight-loss drugs could provide other important health…
Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 Trial
An experimental weight-loss injection has helped people with obesity lose an average of up to 25 per cent…
#EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes – Endpoints News
#EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes Endpoints NewsEli Lilly obesity drug…
Patient suffers torn oesophagus after using unapproved peptide, prompting fresh warnings
A patient who used an unapproved peptide labelled as the weight-loss drug retatrutide has suffered a potentially fatal…
What are the benefits and risks of GLP-1 drugs beyond weight loss?
BATON ROUGE, La. (WAFB/Gray News) — Doctors have used GLP-1 drugs for weight loss for about five years,…
‘Super weight loss’ drug retatrutide could be available soon
KENT COUNTY, Mich — A new weight loss drug could soon be joining the growing list of medications…
Teens Are Injecting Retatrutide, an Unapproved Weight-Loss Peptide Viral on TikTok
Greta sits in her car and sings to the camera: “Greta, reta, bo, beta, banana, fana, fo, feta,…
Teens Are Injecting Retatrutide, an Unapproved Weight-Loss Peptide Viral on TikTok
Greta sits in her car and sings to the camera: “Greta, reta, bo, beta, banana, fana, fo, feta,…
Inside South Africa’s illegal weight-loss drug trade
Story audio is generated using AI People become obese for many reasons. Genetics, the environments they live in,…
Warning issued over counterfeit weight-loss drugs labelled as retatrutide
Senior doctors from a hospital in Melbourne’s north are warning people against taking drugs being labelled as experimental…
Eli Lilly Drug Retatrutide Clinical Trial Results
Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become…
Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…